Hip structural analysis, trabecular bone score, and bone mineral density in post-menopausal women with type-2 diabetes mellitus: a multi-center cross-sectional study in the south of Iran

[1]  N. Thomas,et al.  Utility and validation of bone mineral density measurements at forearm in predicting trabecular microarchitecture and central‐site osteoporosis in aging Indian postmenopausal women—a promising surrogate? , 2022, Aging medicine (Milton (N.S.W)).

[2]  B. Duncan,et al.  IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 , 2021, Diabetes Research and Clinical Practice.

[3]  C. Vázquez,et al.  Obesity in postmenopausal women: causes, prevalence and specific risks: role of decreased , 2021, Advances in Obesity, Weight Management & Control.

[4]  Chul-Hyun Park,et al.  Strong association of type 2 diabetes with degenerative lumbar spine disorders , 2021, Scientific Reports.

[5]  I. Vered,et al.  Bone Mineral Density of the 1/3 Radius Refines Osteoporosis Diagnosis, Correlates With Prevalent Fractures, and Enhances Fracture Risk Estimates. , 2021, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[6]  N. Thomas,et al.  Do proximal hip geometry, trabecular microarchitecture, and prevalent vertebral fractures differ in postmenopausal women with type 2 diabetes mellitus? A cross-sectional study from a teaching hospital in southern India , 2021, Osteoporosis International.

[7]  B. Zemel,et al.  Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Periprosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics. , 2019, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[8]  T. Nguyen,et al.  Association between trabecular bone score and type 2 diabetes: a quantitative update of evidence , 2019, Osteoporosis International.

[9]  M. Paesmans,et al.  Assessment of bone quality with trabecular bone score in type 2 diabetes mellitus: A study from the FRISBEE cohort , 2019, International journal of clinical practice.

[10]  Ming Zhang,et al.  Association of menopause and type 2 diabetes mellitus , 2019, Menopause.

[11]  T. Nguyen,et al.  Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study , 2018, Osteoporosis International.

[12]  C. Ambrose,et al.  Trabecular Bone Score Is a Valuable Addition to Bone Mineral Density for Bone Quality Assessment in Older Mexican American Women With Type 2 Diabetes. , 2018, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[13]  M. Zabihiyeganeh,et al.  A study of the value of trabecular bone score in fracture risk assessment of postmenopausal women. , 2018, Taiwanese journal of obstetrics & gynecology.

[14]  C. Cervellati,et al.  Fracture risk assessment in postmenopausal women with diabetes: comparison between DeFRA and FRAX tools , 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[15]  Frank B. Hu,et al.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications , 2018, Nature Reviews Endocrinology.

[16]  D. Kiel,et al.  Diabetes and Deficits in Cortical Bone Density, Microarchitecture, and Bone Size: Framingham HR‐pQCT Study , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  G. Guglielmi,et al.  Comparison of trabecular bone score and hip structural analysis with FRAX® in postmenopausal women with type 2 diabetes mellitus , 2017, Aging Clinical and Experimental Research.

[18]  M. Amraei,et al.  Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis , 2017, Therapeutics and clinical risk management.

[19]  J. Blümel,et al.  Sedentary lifestyle in middle-aged women is associated with severe menopausal symptoms and obesity , 2016, Menopause.

[20]  Gretchen A. Stevens,et al.  Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants , 2016, Lancet.

[21]  C. Gordon,et al.  Best Practices for Dual-Energy X-ray Absorptiometry Measurement and Reporting: International Society for Clinical Densitometry Guidance. , 2016, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[22]  J. Reginster,et al.  Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. , 2015 .

[23]  T. Beck,et al.  Measurement of Hip Geometry-Technical Background. , 2015, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[24]  J. Cauley,et al.  Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 1: Hip Geometry. , 2015, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[25]  Stephanie Boutroy,et al.  Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 2: Trabecular Bone Score. , 2015, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[26]  H. Choi,et al.  Trabecular bone score as an indicator for skeletal deterioration in diabetes. , 2015, The Journal of clinical endocrinology and metabolism.

[27]  M. Bouxsein,et al.  Defects in cortical microarchitecture among African-American women with type 2 diabetes , 2015, Osteoporosis International.

[28]  I. Dontas,et al.  Type 2 diabetes mellitus and fracture risk. , 2014, Metabolism: clinical and experimental.

[29]  Jacques P. Brown,et al.  Evidence for impaired skeletal load adaptation among Canadian women with type 2 diabetes mellitus: insight into the BMD and bone fragility paradox. , 2013, Metabolism: clinical and experimental.

[30]  A. LaCroix,et al.  Hip geometry in diabetic women: implications for fracture risk. , 2012, Metabolism: clinical and experimental.

[31]  K. Kohara,et al.  Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia , 2012, Menopause.

[32]  J. Kanis,et al.  Type 2 diabetes and bone , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  Lili Ma,et al.  Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies , 2012, European Journal of Epidemiology.

[34]  F. Bandeira,et al.  Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complications. , 2011, Journal of diabetes and its complications.

[35]  Zheng-yuan Zhou,et al.  Evidence on the applicability of the ATPIII, IDF and CDS metabolic syndrome diagnostic criteria to identify CVD and T2DM in the Chinese population from a 6.3-year cohort study in mid-eastern China. , 2010, Diabetes research and clinical practice.

[36]  S. Majumdar,et al.  High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. , 2010, Journal of Clinical Endocrinology and Metabolism.

[37]  M. Isidro,et al.  Bone disease in diabetes. , 2010, Current diabetes reviews.

[38]  Maria Luisa Brandi,et al.  Microarchitecture, the key to bone quality. , 2009, Rheumatology.

[39]  Xu Feng,et al.  Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease. , 2009, Current chemical biology.

[40]  Sydney Lou Bonnick,et al.  HSA: beyond BMD with DXA. , 2007, Bone.

[41]  Thomas J Beck,et al.  Extending DXA beyond bone mineral density: Understanding hip structure analysis , 2007, Current osteoporosis reports.

[42]  R. Freeman.  Are blood glucose levels affected by menopause? , 2007, Menopause.

[43]  Karen C Johnson,et al.  Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. , 2006, The Journal of clinical endocrinology and metabolism.

[44]  S. F,et al.  The Relationship Between Type 2 Diabetes Mellitus And Bone Density In Postmenopausal Women , 2006 .

[45]  M. Shigemoto,et al.  Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients , 2005, Osteoporosis International.

[46]  S. Majumdar,et al.  Current diagnostic techniques in the evaluation of bone architecture , 2004, Current osteoporosis reports.

[47]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[48]  Yu-Ching Lin,et al.  Vertebral Fractures in Type 2 Diabetes Patients: Utility of Trabecular Bone Score and Relationship With Serum Bone Turnover Biomarkers. , 2019, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[49]  C. Fiore,et al.  The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients , 2015, Osteoporosis International.

[50]  I. Anaforoglu,et al.  Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes. , 2009, Journal of diabetes and its complications.